Authors:
Bush, MA
Samara, E
Whitehouse, MJ
Yoshizawa, C
Novicki, DL
Pike, M
Laham, RJ
Simons, M
Chronos, NA
Citation: Ma. Bush et al., Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease, J CLIN PHAR, 41(4), 2001, pp. 378-385
Authors:
Karwatowski, SP
Chronos, NA
Sinclaire, H
Forbat, SM
Sutton, MGS
Black, C
Underwood, SR
Pennell, DJ
Citation: Sp. Karwatowski et al., Effect of systemic sclerosis on left ventricular long-axis motion and leftventricular mass assessed by magnetic resonance, J CARD M RE, 2(2), 2000, pp. 109-117
Authors:
Laham, RJ
Chronos, NA
Pike, M
Leimbach, ME
Udelson, JE
Pearlman, JD
Pettigrew, RI
Whitehouse, MJ
Yoshizawa, C
Simons, M
Citation: Rj. Laham et al., Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study, J AM COL C, 36(7), 2000, pp. 2132-2139